scholarly article | Q13442814 |
P50 | author | Sin-Hee Park | Q87995648 |
Cyril Auger | Q89529698 | ||
P2093 | author name string | Florence Toti | |
Valérie B Schini-Kerth | |||
Sonia Khemais-Benkhiat | |||
Brigitte Pollet | |||
Dominique Stephan | |||
Sébastien Gaertner | |||
Muhammad A Farooq | |||
Sophie Schrevens | |||
Zahid R Niazi | |||
P2860 | cites work | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association | Q22241921 |
Omega-3 fatty acids for intermittent claudication | Q24201333 | ||
Omega 3 fatty acids for prevention and treatment of cardiovascular disease | Q24245810 | ||
PUFAs: Structures, Metabolism and Functions | Q26771687 | ||
The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis | Q26852020 | ||
Omega-3 polyunsaturated fatty acids and cardiovascular diseases | Q27863409 | ||
Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation | Q28210028 | ||
Dose translation from animal to human studies revisited | Q29618049 | ||
A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk | Q30239801 | ||
Eicosapentaenoic acid (EPA) induces Ca(2+)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation | Q31860738 | ||
Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. | Q52394816 | ||
Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH | Q56964516 | ||
Dietary omega-3 alpha-linolenic acid does not prevent venous thrombosis in mice | Q57618798 | ||
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia | Q58480971 | ||
Differential vasoconstrictor potencies of free fatty acids in the lung vasculature: 2-versus 3-series prostanoid generation | Q60364517 | ||
Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study | Q73836575 | ||
Incidence and mortality of venous thrombosis: a population-based study | Q79969827 | ||
Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammation | Q86034497 | ||
Association between hospitalization for acute medical illness and VTE risk: A lower efficacy of thromboprophylaxis in elderly patients? Results from the EDITH case-control study | Q88383803 | ||
Marine OMEGA-3 fatty acids in the prevention of cardiovascular disease | Q89112226 | ||
EPA:DHA 6:1 is a superior omega-3 PUFAs formulation attenuating platelets-induced contractile responses in porcine coronary and human internal mammary artery by targeting the serotonin pathway via an increased endothelial formation of nitric oxide | Q92411091 | ||
Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles | Q92790940 | ||
Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials | Q33745366 | ||
The importance of the ratio of omega-6/omega-3 essential fatty acids | Q33962634 | ||
Redox-sensitive induction of Src/PI3-kinase/Akt and MAPKs pathways activate eNOS in response to EPA:DHA 6:1 | Q34061779 | ||
Risk assessment for recurrent venous thrombosis | Q34153343 | ||
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. | Q34275370 | ||
Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report | Q34513594 | ||
Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids | Q34800981 | ||
The epidemiology of venous thromboembolism. | Q35157791 | ||
Omega-3 fatty acids and inflammatory processes | Q35670928 | ||
Age-related decline in prostacyclin synthesis by human aortic endothelial cells. Qualitative and quantitative analysis | Q35830481 | ||
eNOS uncoupling and endothelial dysfunction in aged vessels | Q37431006 | ||
Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. | Q37593747 | ||
Age-related alterations in endothelial function of femoral artery in young SHR and WKY rats. | Q37687931 | ||
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study | Q38497226 | ||
Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps | Q38619530 | ||
Venous thromboembolism in the elderly: A narrative review. | Q38678220 | ||
Aging decreases the production of PGI2 in rat aortic endothelial cells | Q42462845 | ||
The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology | Q42684909 | ||
Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids | Q43264532 | ||
Resolvin D1 reverses reactivity and Ca2+ sensitivity induced by ET-1, TNF-α, and IL-6 in the human pulmonary artery. | Q44733587 | ||
Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension | Q46868364 | ||
EPA:DHA 6:1 prevents angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase- and COX-derived oxidative stress. | Q47845782 | ||
Omega-3 polyunsaturated fatty acids reduce vascular tone and inflammation in human saphenous vein. | Q47909305 | ||
Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response | Q47976088 | ||
Increased risk and severity of unprovoked venous thromboembolism with clustering cardiovascular risk factors for atherosclerosis: Results of the REMOTEV registry | Q49702848 | ||
Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism. | Q50129776 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P577 | publication date | 2020-01-30 | |
P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
P1476 | title | Oral Intake of EPA:DHA 6:1 by Middle-Aged Rats for One Week Improves Age-Related Endothelial Dysfunction in Both the Femoral Artery and Vein: Role of Cyclooxygenases | |
P478 | volume | 21 |
Search more.